Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testicular Neoplasms | 10 | 2017 | 19 | 1.960 |
Why?
|
| Wilms Tumor | 7 | 2011 | 10 | 1.240 |
Why?
|
| Ureteral Obstruction | 7 | 2008 | 21 | 1.160 |
Why?
|
| Kidney Neoplasms | 7 | 2011 | 80 | 1.160 |
Why?
|
| Child | 32 | 2017 | 1410 | 1.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 5 | 2017 | 6 | 0.990 |
Why?
|
| Ureter | 6 | 2008 | 29 | 0.990 |
Why?
|
| Nephrectomy | 8 | 2011 | 40 | 0.960 |
Why?
|
| Urologists | 2 | 2016 | 3 | 0.690 |
Why?
|
| Child, Preschool | 19 | 2017 | 678 | 0.630 |
Why?
|
| Infant | 22 | 2017 | 591 | 0.620 |
Why?
|
| Hypospadias | 4 | 2010 | 4 | 0.610 |
Why?
|
| Urinary Fistula | 2 | 2008 | 4 | 0.590 |
Why?
|
| Kidney Pelvis | 4 | 2008 | 17 | 0.580 |
Why?
|
| Pediatricians | 1 | 2016 | 4 | 0.550 |
Why?
|
| Urology | 2 | 2015 | 17 | 0.540 |
Why?
|
| Health Care Surveys | 1 | 2016 | 66 | 0.540 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 157 | 0.530 |
Why?
|
| Medical Oncology | 1 | 2016 | 43 | 0.530 |
Why?
|
| Male | 42 | 2017 | 15173 | 0.510 |
Why?
|
| Orchiectomy | 2 | 2015 | 4 | 0.510 |
Why?
|
| Physician's Role | 1 | 2015 | 19 | 0.500 |
Why?
|
| Urethra | 5 | 2010 | 15 | 0.500 |
Why?
|
| Vesico-Ureteral Reflux | 4 | 2001 | 6 | 0.490 |
Why?
|
| Urinary Bladder | 3 | 2006 | 22 | 0.490 |
Why?
|
| Humans | 50 | 2017 | 28117 | 0.470 |
Why?
|
| Cystostomy | 3 | 2004 | 5 | 0.470 |
Why?
|
| Kidney | 4 | 2006 | 174 | 0.460 |
Why?
|
| Laparoscopy | 4 | 2010 | 199 | 0.460 |
Why?
|
| Testicular Diseases | 2 | 2010 | 15 | 0.440 |
Why?
|
| Urologic Surgical Procedures, Male | 4 | 2010 | 23 | 0.400 |
Why?
|
| Neoplasms | 1 | 2015 | 236 | 0.400 |
Why?
|
| Cutaneous Fistula | 2 | 2010 | 4 | 0.400 |
Why?
|
| Cryptorchidism | 2 | 2010 | 4 | 0.390 |
Why?
|
| Ovarian Neoplasms | 3 | 2017 | 70 | 0.380 |
Why?
|
| Neoplasm Seeding | 1 | 2011 | 9 | 0.370 |
Why?
|
| Intraoperative Complications | 1 | 2011 | 66 | 0.350 |
Why?
|
| Adolescent | 14 | 2017 | 2291 | 0.350 |
Why?
|
| Forehead | 1 | 2010 | 3 | 0.350 |
Why?
|
| Cosmetic Techniques | 1 | 2010 | 5 | 0.350 |
Why?
|
| Lithiasis | 1 | 2010 | 2 | 0.350 |
Why?
|
| Hydronephrosis | 3 | 2008 | 9 | 0.340 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 56 | 0.340 |
Why?
|
| Infant, Newborn | 9 | 2017 | 660 | 0.310 |
Why?
|
| Preoperative Care | 1 | 2009 | 125 | 0.310 |
Why?
|
| Urethral Diseases | 1 | 2008 | 3 | 0.310 |
Why?
|
| Polyps | 1 | 2008 | 3 | 0.310 |
Why?
|
| Ureteral Neoplasms | 1 | 2008 | 7 | 0.310 |
Why?
|
| Prenatal Diagnosis | 1 | 2008 | 18 | 0.300 |
Why?
|
| Rectal Fistula | 1 | 2006 | 1 | 0.280 |
Why?
|
| Anal Canal | 1 | 2006 | 3 | 0.280 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 14 | 0.280 |
Why?
|
| Fetus | 1 | 2004 | 40 | 0.240 |
Why?
|
| Cystitis | 1 | 2004 | 12 | 0.230 |
Why?
|
| Eosinophilia | 1 | 2004 | 37 | 0.220 |
Why?
|
| Female | 20 | 2017 | 15583 | 0.210 |
Why?
|
| Registries | 2 | 2002 | 182 | 0.200 |
Why?
|
| Postoperative Complications | 6 | 2010 | 930 | 0.180 |
Why?
|
| Pediatrics | 2 | 2015 | 47 | 0.170 |
Why?
|
| Combined Modality Therapy | 3 | 2009 | 306 | 0.160 |
Why?
|
| Surgical Flaps | 2 | 2010 | 51 | 0.160 |
Why?
|
| Pregnancy | 3 | 2008 | 341 | 0.160 |
Why?
|
| Lymphedema | 1 | 1998 | 4 | 0.160 |
Why?
|
| Societies, Medical | 2 | 2016 | 153 | 0.160 |
Why?
|
| Testis | 3 | 2015 | 11 | 0.160 |
Why?
|
| Genital Diseases, Male | 1 | 1998 | 8 | 0.160 |
Why?
|
| Urinary Tract Infections | 1 | 1999 | 33 | 0.160 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1998 | 28 | 0.150 |
Why?
|
| Adult | 13 | 2017 | 8036 | 0.150 |
Why?
|
| Choristoma | 1 | 1998 | 5 | 0.150 |
Why?
|
| Gonadal Dysgenesis | 1 | 2017 | 1 | 0.150 |
Why?
|
| Christianity | 1 | 1997 | 6 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2014 | 3537 | 0.150 |
Why?
|
| Age Factors | 3 | 2010 | 790 | 0.150 |
Why?
|
| Religion and Medicine | 1 | 1997 | 24 | 0.150 |
Why?
|
| Testicular Hydrocele | 2 | 1999 | 6 | 0.140 |
Why?
|
| Urologic Surgical Procedures | 1 | 2016 | 11 | 0.140 |
Why?
|
| Surgical Oncology | 1 | 2016 | 6 | 0.140 |
Why?
|
| Follow-Up Studies | 6 | 2015 | 1811 | 0.130 |
Why?
|
| Neoplasm Staging | 4 | 2017 | 372 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2015 | 3531 | 0.130 |
Why?
|
| Replantation | 1 | 1995 | 10 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 121 | 0.120 |
Why?
|
| Young Adult | 3 | 2010 | 2048 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 244 | 0.120 |
Why?
|
| United States | 2 | 2016 | 2161 | 0.120 |
Why?
|
| Data Collection | 1 | 2014 | 98 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 206 | 0.110 |
Why?
|
| Epidermal Cyst | 1 | 1993 | 5 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 1994 | 131 | 0.100 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 2 | 2002 | 2 | 0.100 |
Why?
|
| Abdomen | 1 | 1992 | 8 | 0.100 |
Why?
|
| Scrotum | 1 | 1992 | 14 | 0.100 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 177 | 0.100 |
Why?
|
| Penis | 3 | 2009 | 82 | 0.090 |
Why?
|
| Balanitis Xerotica Obliterans | 1 | 2010 | 1 | 0.090 |
Why?
|
| Urethral Stricture | 1 | 2010 | 7 | 0.090 |
Why?
|
| Middle Aged | 7 | 2016 | 9188 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2010 | 232 | 0.090 |
Why?
|
| Rejuvenation | 1 | 2010 | 3 | 0.090 |
Why?
|
| Kidney Calices | 1 | 1990 | 1 | 0.090 |
Why?
|
| Risk Factors | 3 | 2017 | 2375 | 0.090 |
Why?
|
| Time Factors | 3 | 2008 | 1489 | 0.090 |
Why?
|
| Circumcision, Male | 2 | 2000 | 8 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2017 | 1763 | 0.080 |
Why?
|
| Endodermal Sinus Tumor | 2 | 2002 | 3 | 0.080 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2009 | 1 | 0.080 |
Why?
|
| Sexual Development | 1 | 2009 | 1 | 0.080 |
Why?
|
| Survival Rate | 2 | 2017 | 355 | 0.080 |
Why?
|
| Fertility | 1 | 2009 | 18 | 0.080 |
Why?
|
| Prevalence | 1 | 2010 | 466 | 0.080 |
Why?
|
| Twins | 1 | 2008 | 8 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2011 | 665 | 0.070 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 10 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 321 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2006 | 57 | 0.070 |
Why?
|
| Prognosis | 2 | 2015 | 819 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2008 | 221 | 0.070 |
Why?
|
| Disease Progression | 1 | 2008 | 718 | 0.060 |
Why?
|
| Multicystic Dysplastic Kidney | 1 | 2005 | 1 | 0.060 |
Why?
|
| alpha-Fetoproteins | 2 | 2002 | 3 | 0.060 |
Why?
|
| Papilloma | 1 | 2005 | 3 | 0.060 |
Why?
|
| Uterus | 1 | 2004 | 14 | 0.060 |
Why?
|
| Sheep | 1 | 2004 | 19 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2005 | 35 | 0.060 |
Why?
|
| Recurrence | 2 | 2010 | 318 | 0.060 |
Why?
|
| Urinary Bladder Diseases | 1 | 2004 | 8 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2004 | 231 | 0.060 |
Why?
|
| Sertoli Cell Tumor | 1 | 2002 | 1 | 0.050 |
Why?
|
| Sports | 1 | 2002 | 47 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 991 | 0.050 |
Why?
|
| Animals | 3 | 2009 | 3828 | 0.050 |
Why?
|
| Patient Education as Topic | 2 | 2002 | 161 | 0.050 |
Why?
|
| Neoplasms, Second Primary | 1 | 2001 | 40 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 49 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2001 | 155 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2002 | 172 | 0.040 |
Why?
|
| Algorithms | 1 | 2002 | 371 | 0.040 |
Why?
|
| Prune Belly Syndrome | 1 | 1999 | 1 | 0.040 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 1999 | 3 | 0.040 |
Why?
|
| Spermatozoa | 1 | 1999 | 9 | 0.040 |
Why?
|
| Infertility, Male | 1 | 1999 | 6 | 0.040 |
Why?
|
| Aged | 4 | 2016 | 9223 | 0.040 |
Why?
|
| Hernia, Inguinal | 1 | 1999 | 22 | 0.040 |
Why?
|
| Teaching Materials | 1 | 1999 | 9 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1999 | 6 | 0.040 |
Why?
|
| Vena Cava, Inferior | 1 | 1999 | 11 | 0.040 |
Why?
|
| Urography | 1 | 1998 | 3 | 0.040 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 1998 | 5 | 0.040 |
Why?
|
| Hemodilution | 1 | 1997 | 2 | 0.040 |
Why?
|
| Varicocele | 1 | 1997 | 3 | 0.040 |
Why?
|
| Hemostasis, Surgical | 1 | 1997 | 15 | 0.040 |
Why?
|
| Teratoma | 1 | 1997 | 4 | 0.040 |
Why?
|
| Stents | 1 | 1998 | 85 | 0.040 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1997 | 42 | 0.040 |
Why?
|
| Bleomycin | 1 | 2017 | 2 | 0.040 |
Why?
|
| Etoposide | 1 | 2017 | 26 | 0.040 |
Why?
|
| North America | 1 | 2016 | 41 | 0.030 |
Why?
|
| Cisplatin | 1 | 2017 | 53 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 165 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2000 | 318 | 0.030 |
Why?
|
| Certification | 1 | 2016 | 49 | 0.030 |
Why?
|
| Surgeons | 1 | 2016 | 89 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2015 | 12 | 0.030 |
Why?
|
| Graft Survival | 1 | 1994 | 102 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 1993 | 27 | 0.030 |
Why?
|
| Retroperitoneal Space | 1 | 1992 | 8 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 24 | 0.020 |
Why?
|
| Parabiosis | 1 | 1990 | 2 | 0.020 |
Why?
|
| Renal Artery Obstruction | 1 | 1990 | 2 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 1990 | 30 | 0.020 |
Why?
|
| Thrombosis | 1 | 1990 | 57 | 0.020 |
Why?
|
| Semen Analysis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Sperm Count | 1 | 2009 | 3 | 0.020 |
Why?
|
| Epididymis | 1 | 2009 | 6 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 1998 | 4846 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 325 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 449 | 0.020 |
Why?
|
| Reoperation | 1 | 2010 | 906 | 0.020 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2005 | 3 | 0.020 |
Why?
|
| Colposcopy | 1 | 2005 | 2 | 0.020 |
Why?
|
| Electrocoagulation | 1 | 2005 | 13 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2005 | 81 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 1495 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 370 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 206 | 0.010 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2001 | 2 | 0.010 |
Why?
|
| Survivors | 1 | 2001 | 72 | 0.010 |
Why?
|
| Endoscopes | 1 | 2000 | 9 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 2000 | 12 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 758 | 0.010 |
Why?
|
| Suction | 1 | 1999 | 37 | 0.010 |
Why?
|
| Puberty | 1 | 1997 | 10 | 0.010 |
Why?
|
| Ligation | 1 | 1997 | 38 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1996 | 110 | 0.010 |
Why?
|
| Inulin | 1 | 1990 | 1 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 1990 | 6 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1990 | 23 | 0.010 |
Why?
|
| Creatinine | 1 | 1990 | 53 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 1990 | 52 | 0.010 |
Why?
|
| Rats | 1 | 1990 | 675 | 0.000 |
Why?
|